Results 171 to 180 of about 430,537 (306)
Objectives There is growing interest in evaluating new strategies to delay or prevent post‐traumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury.
Kevin Kennedy +9 more
wiley +1 more source
On the Coupling Between Cosmological Dynamics and Quantum Behavior: A Multiscale Thermodynamic Framework. [PDF]
Warkentin A.
europepmc +1 more source
Large-scale structure of the Universe. The Zeldovich approximation and the adhesion model
С. Н. Гурбатов +2 more
openalex +1 more source
QUASARS AS A TRACER OF LARGE-SCALE STRUCTURES IN THE DISTANT UNIVERSE [PDF]
Hyunmi Song +3 more
openalex +1 more source
Objective We aimed to test the efficacy of personalized treatment of older Veterans with chronic low back pain (CLBP) delivered by Aging Back Clinics (ABC) as compared with usual care (UC). Methods Two hundred ninety‐nine Veterans age 65‐89 with CLBP from 3 VA medical centers underwent baseline testing, randomization to ABC or UC and 12 months follow ...
Debra K. Weiner +9 more
wiley +1 more source
Counting Cosmic Cycles: Past Big Crunches, Future Recurrence Limits, and the Age of the Quantum Memory Matrix Universe. [PDF]
Neukart F, Marx E, Vinokur V.
europepmc +1 more source
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source
Exploring the extremes: The cosmic laboratory. [PDF]
Huang Y, He S, Ge L, Li Z, Mao Y, Liu J.
europepmc +1 more source
Sex differences in medication discontinuation in axial spondyloarthritis.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or Janus kinase inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we ...
Rachael Stovall +9 more
wiley +1 more source

